143 related articles for article (PubMed ID: 21398573)
1. Commentary on an article by Rick Delamarter, MD, et al.: "Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level degenerative lumbar disc disease. Results at twenty-four months".
Schoenfeld AJ
J Bone Joint Surg Am; 2011 Apr; 93(8):e41. PubMed ID: 21398573
[No Abstract] [Full Text] [Related]
2. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level lumbar degenerative disc disease: results at twenty-four months.
Delamarter R; Zigler JE; Balderston RA; Cammisa FP; Goldstein JA; Spivak JM
J Bone Joint Surg Am; 2011 Apr; 93(8):705-15. PubMed ID: 21398574
[TBL] [Abstract][Full Text] [Related]
3. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease.
Zigler J; Delamarter R; Spivak JM; Linovitz RJ; Danielson GO; Haider TT; Cammisa F; Zuchermann J; Balderston R; Kitchel S; Foley K; Watkins R; Bradford D; Yue J; Yuan H; Herkowitz H; Geiger D; Bendo J; Peppers T; Sachs B; Girardi F; Kropf M; Goldstein J
Spine (Phila Pa 1976); 2007 May; 32(11):1155-62; discussion 1163. PubMed ID: 17495770
[TBL] [Abstract][Full Text] [Related]
4. Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
Fairbank J
Spine (Phila Pa 1976); 2007 Dec; 32(25):2929-30; author reply 2930-1. PubMed ID: 18246024
[No Abstract] [Full Text] [Related]
5. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up.
Guyer RD; McAfee PC; Banco RJ; Bitan FD; Cappuccino A; Geisler FH; Hochschuler SH; Holt RT; Jenis LG; Majd ME; Regan JJ; Tromanhauser SG; Wong DC; Blumenthal SL
Spine J; 2009 May; 9(5):374-86. PubMed ID: 18805066
[TBL] [Abstract][Full Text] [Related]
6. Lumbar disc arthroplasty with Maverick disc versus stand-alone interbody fusion: a prospective, randomized, controlled, multicenter investigational device exemption trial.
Gornet MF; Burkus JK; Dryer RF; Peloza JH
Spine (Phila Pa 1976); 2011 Dec; 36(25):E1600-11. PubMed ID: 21415812
[TBL] [Abstract][Full Text] [Related]
7. Prospective, randomized trial of metal-on-metal artificial lumbar disc replacement: initial results for treatment of discogenic pain.
Sasso RC; Foulk DM; Hahn M
Spine (Phila Pa 1976); 2008 Jan; 33(2):123-31. PubMed ID: 18197095
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized, multicenter Food and Drug Administration investigational device exemptions study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part I: evaluation of clinical outcomes.
Blumenthal S; McAfee PC; Guyer RD; Hochschuler SH; Geisler FH; Holt RT; Garcia R; Regan JJ; Ohnmeiss DD
Spine (Phila Pa 1976); 2005 Jul; 30(14):1565-75; discussion E387-91. PubMed ID: 16025024
[TBL] [Abstract][Full Text] [Related]
9. Five-year results of the prospective, randomized, multicenter, Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential arthrodesis for the treatment of single-level degenerative disc disease.
Zigler JE; Delamarter RB
J Neurosurg Spine; 2012 Dec; 17(6):493-501. PubMed ID: 23082846
[TBL] [Abstract][Full Text] [Related]
10. Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease.
Murrey D; Janssen M; Delamarter R; Goldstein J; Zigler J; Tay B; Darden B
Spine J; 2009 Apr; 9(4):275-86. PubMed ID: 18774751
[TBL] [Abstract][Full Text] [Related]
11. Comparative charge analysis of one- and two-level lumbar total disc arthroplasty versus circumferential lumbar fusion.
Levin DA; Bendo JA; Quirno M; Errico T; Goldstein J; Spivak J
Spine (Phila Pa 1976); 2007 Dec; 32(25):2905-9. PubMed ID: 18246016
[TBL] [Abstract][Full Text] [Related]
12. ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease: Seven-Year Follow-up of the Prospective Randomized U.S. Food and Drug Administration Investigational Device Exemption Study.
Janssen ME; Zigler JE; Spivak JM; Delamarter RB; Darden BV; Kopjar B
J Bone Joint Surg Am; 2015 Nov; 97(21):1738-47. PubMed ID: 26537161
[TBL] [Abstract][Full Text] [Related]
13. Artificial vertebral disc replacement.
Technol Eval Cent Assess Program Exec Summ; 2005 Apr; 20(1):1-2. PubMed ID: 15880888
[No Abstract] [Full Text] [Related]
14. Neurological complications of lumbar artificial disc replacement and comparison of clinical results with those related to lumbar arthrodesis in the literature: results of a multicenter, prospective, randomized investigational device exemption study of Charité intervertebral disc. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
Geisler FH; Blumenthal SL; Guyer RD; McAfee PC; Regan JJ; Johnson JP; Mullin B
J Neurosurg Spine; 2004 Sep; 1(2):143-54. PubMed ID: 15346999
[TBL] [Abstract][Full Text] [Related]
15. ProDisc artificial total lumbar disc replacement: introduction and early results from the United States clinical trial.
Delamarter RB; Fribourg DM; Kanim LE; Bae H
Spine (Phila Pa 1976); 2003 Oct; 28(20):S167-75. PubMed ID: 14560188
[TBL] [Abstract][Full Text] [Related]
16. ProDisc-C and anterior cervical discectomy and fusion as surgical treatment for single-level cervical symptomatic degenerative disc disease: five-year results of a Food and Drug Administration study.
Zigler JE; Delamarter R; Murrey D; Spivak J; Janssen M
Spine (Phila Pa 1976); 2013 Feb; 38(3):203-9. PubMed ID: 23080427
[TBL] [Abstract][Full Text] [Related]
17. A comparison of patients who have undergone 1-Level versus 2-Level ProDisc arthroplasty: a prospective study with minimum of 5-year follow-up.
Yue J; Zhang K; Bai HX; Du J; Cammisa F; Abjornson C; Mo F
Spine (Phila Pa 1976); 2013 Jun; 38(14):1194-8. PubMed ID: 23392415
[TBL] [Abstract][Full Text] [Related]
18. Artificial lumbar disc arthroplasty.
; ;
Technol Eval Cent Assess Program Exec Summ; 2014 Jan; 28(7):1-3. PubMed ID: 24730083
[No Abstract] [Full Text] [Related]
19. Lumbar total disc arthroplasty in patients older than 60 years of age: a prospective study of the ProDisc prosthesis with 2-year minimum follow-up period.
Bertagnoli R; Yue JJ; Nanieva R; Fenk-Mayer A; Husted DS; Shah RV; Emerson JW
J Neurosurg Spine; 2006 Feb; 4(2):85-90. PubMed ID: 16506473
[TBL] [Abstract][Full Text] [Related]
20. Lumbar spine arthroplasty using the ProDisc II.
Zigler JE
Spine J; 2004; 4(6 Suppl):260S-267S. PubMed ID: 15541675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
